You are here

  • Home
  • Archive
  • Volume 11, Issue 1
  • Correction: Virtual clinical trials of anti-PD-1 and anti-CTLA-4 immunotherapy in advanced hepatocellular carcinoma using a quantitative systems pharmacology model

Article Text

Article menu

See original article:

Download PDFPDF

Correction
Correction: Virtual clinical trials of anti-PD-1 and anti-CTLA-4 immunotherapy in advanced hepatocellular carcinoma using a quantitative systems pharmacology model

https://doi.org/10.1136/jitc-2022-005414corr1

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Sové RJ, Verma BK, Wang H, et al. Virtual clinical trials of anti-PD-1 and anti-CTLA-4 immunotherapy in advanced hepatocellular carcinoma using a quantitative systems pharmacology model. J ImmunoTher Cancer 2022;10:e005414. doi: 10.1136/jitc-2022-005414.

    This article has been corrected since it was first published to indicate that RJS and BKV are joint first authors.